Micropaque Suspensie

Barium sulfate, the active ingredient in Micropaque Suspensie, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque coating of the gastrointestinal tract, enabling clear visualization of the lumen during X‑ray imaging procedures, and is employed in patients undergoing diagnostic gastrointestinal studies.

GNH USA supplies Micropaque Suspensie as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company ensures quality compliance with EU standards and provides reliable logistics for global distribution. It supports procurement teams and clinical pharmacies with timely delivery and regulatory assistance.

Micropaque is a barium sulfate suspension used in gastrointestinal radiographic procedures to enhance X‑ray image contrast. - Gastrointestinal radiography: enables clear visualization of the entire GI lumen during standard X‑ray examinations. - Esophageal barium study: outlines the esophageal contour and detects strictures or motility disorders. - Stomach and duodenal study: highlights gastric anatomy and ulcerations for diagnostic assessment. - Small‑intestine (enteric) study: delineates mucosal patterns and detects malabsorption or inflammatory lesions. - Colon (barium enema) study: provides detailed imaging of the colonic wall and lumen for polyp or cancer screening.

Barium sulfate suspension may cause gastrointestinal and systemic reactions, ranging from mild discomfort to rare serious events.

Common Side Effects: - Constipation: difficulty passing stool after the procedure. - Abdominal discomfort: cramping or mild pain in the abdomen. - Nausea or vomiting: transient feeling of nausea or vomiting. - Metallic taste: temporary metallic sensation in the mouth.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or anaphylaxis in hypersensitive individuals. - Aspiration pneumonitis: inhalation of the suspension leading to lung inflammation. - Bowel perforation: rare tearing of the gastrointestinal wall. - Intestinal obstruction: blockage caused by retained contrast material.

Before using Micropaque, consider the following precautions to ensure patient safety and optimal imaging results. - Assess for bowel obstruction: avoid use in patients with known or suspected obstruction. - Check for hypersensitivity: contraindicated in individuals with known allergy to barium sulfate. - Recent gastrointestinal surgery: use with caution due to risk of perforation. - Pregnancy and lactation: limited safety data; use only if benefits outweigh risks. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Barium sulfate may interact with certain medications and diagnostic agents; awareness of these interactions helps prevent compromised imaging or therapeutic efficacy.

Major Interactions (Avoid): - Concurrent oral iron supplements: may reduce radiographic contrast quality. - Tetracycline antibiotics: chelation can diminish barium suspension opacity.

Moderate Interactions (Monitor Closely): - Fluoroquinolone antibiotics: potential for reduced absorption when taken with barium. - Levothyroxine: barium may interfere with thyroid hormone absorption; separate dosing times. - Radiopharmaceuticals: barium may obscure nuclear imaging results if administered closely.